Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Chuansumrit, A; Sri-Udomporn, N; Srimuninnimit, V; Juntarukha, R
   A single high dose of recombinant factor VIIa combining adjuvant therapy for controlling bleeding episodes in haemophiliacs with inhibitors
   HAEMOPHILIA
   
   A. Chuansumrit et al., "A single high dose of recombinant factor VIIa combining adjuvant therapy for controlling bleeding episodes in haemophiliacs with inhibitors", HAEMOPHILIA, 7(5), 2001, pp. 532-534
2. Faradji, A; Bonnomet, F; Lecocq, J; Grunebaum, L; Desprez, D; Kern, O; Barbier, L; Sibilia, J
   Knee joint arthroplasty in a patient with haemophilia A and high inhibitortitre using recombinant factor VIIa (NovoSeven((R))): a new case report and review of the literature
   HAEMOPHILIA
   
   A. Faradji et al., "Knee joint arthroplasty in a patient with haemophilia A and high inhibitortitre using recombinant factor VIIa (NovoSeven((R))): a new case report and review of the literature", HAEMOPHILIA, 7(3), 2001, pp. 321-326
3. Grunewald, M; Beneke, H; Guthner, C; Germowitz, A; Brommer, A; Griesshammer, M
   Acquired haemophilia: experiences with a standardized approach
   HAEMOPHILIA
   
   M. Grunewald et al., "Acquired haemophilia: experiences with a standardized approach", HAEMOPHILIA, 7(2), 2001, pp. 164-169
4. Hoots, WK
   The future of plasma-derived clotting factor concentrates
   HAEMOPHILIA
   
   W.K. Hoots, "The future of plasma-derived clotting factor concentrates", HAEMOPHILIA, 7, 2001, pp. 4-9
5. Castro, RR; Relinque, NB; Alvarez, AC; Montes, JMG; Gutierrez, JMH
   Use of recombinant factor VII in Hepatology
   REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
   
   R.R. Castro et al., "Use of recombinant factor VII in Hepatology", REV ESP E D, 93(10), 2001, pp. 664-668
6. Poon, MC
   Use of recombinant factor VIIa in hereditary bleeding disorders
   CURRENT OPINION IN HEMATOLOGY
   
   M.C. Poon, "Use of recombinant factor VIIa in hereditary bleeding disorders", CURR OPIN H, 8(5), 2001, pp. 312-318
7. Mutanen, M; Freese, R
   Fats, lipids and blood coagulation
   CURRENT OPINION IN LIPIDOLOGY
   
   M. Mutanen e R. Freese, "Fats, lipids and blood coagulation", CURR OP LIP, 12(1), 2001, pp. 25-29
8. Cardigan, RA; Crook, M; Mackie, IJ; Machin, SJ
   Plasma levels of factor XIIa and factor VIIa are increased but not relatedin primary hyperlipidaemia
   BLOOD COAGULATION & FIBRINOLYSIS
   
   R.A. Cardigan et al., "Plasma levels of factor XIIa and factor VIIa are increased but not relatedin primary hyperlipidaemia", BL COAG FIB, 12(3), 2001, pp. 187-192
9. Berrettini, M; Mariani, G; Schiavoni, M; Rocino, A; Di Paolantonio, T; Longo, G; Morfini, M
   Pharmacokinetic evaluation of recombinant, activated factor VII in patients with inherited factor VII deficiency
   HAEMATOLOGICA
   
   M. Berrettini et al., "Pharmacokinetic evaluation of recombinant, activated factor VII in patients with inherited factor VII deficiency", HAEMATOLOG, 86(6), 2001, pp. 640-645
10. Mariani, G; Kroner, B
    Immune tolerance in hemophilia with factor VIII inhibitors: predictors of success
    HAEMATOLOGICA
    
    G. Mariani e B. Kroner, "Immune tolerance in hemophilia with factor VIII inhibitors: predictors of success", HAEMATOLOG, 86(11), 2001, pp. 1186-1193
11. Ewenstein, BM
    Continuous infusion of recombinant factor VIIa: Continue or not?
    THROMBOSIS AND HAEMOSTASIS
    
    B.M. Ewenstein, "Continuous infusion of recombinant factor VIIa: Continue or not?", THROMB HAEM, 86(4), 2001, pp. 942-944
12. Santagostino, E; Morfini, M; Rocino, A; Baudo, F; Scaraggi, FA; Gringeri, A
    Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors
    THROMBOSIS AND HAEMOSTASIS
    
    E. Santagostino et al., "Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors", THROMB HAEM, 86(4), 2001, pp. 954-958
13. Konigsberg, W; Kirchhofer, D; Riederer, MA; Nemerson, Y
    The TF : VIIa complex: Clinical significance, structure-function relationships and its role in signaling and metastasis
    THROMBOSIS AND HAEMOSTASIS
    
    W. Konigsberg et al., "The TF : VIIa complex: Clinical significance, structure-function relationships and its role in signaling and metastasis", THROMB HAEM, 86(3), 2001, pp. 757-771
14. Morrissey, JH
    Tissue factor: An enzyme cofactor and a true receptor
    THROMBOSIS AND HAEMOSTASIS
    
    J.H. Morrissey, "Tissue factor: An enzyme cofactor and a true receptor", THROMB HAEM, 86(1), 2001, pp. 66-74
15. Eriksson-Berg, M; Silveira, A; Orth-Gomer, K; Hamsten, A; Schenck-Gustafsson, K
    Coagulation factor VII in middle-aged women with and without coronary heart disease
    THROMBOSIS AND HAEMOSTASIS
    
    M. Eriksson-Berg et al., "Coagulation factor VII in middle-aged women with and without coronary heart disease", THROMB HAEM, 85(5), 2001, pp. 787-792
16. Blatt, J; Gold, SH; Wiley, JM; Monahan, PE; Cooper, HC; Harvey, D
    Off-label use of recombinant factor VIIa in patients following bone marrowtransplantation
    BONE MARROW TRANSPLANTATION
    
    J. Blatt et al., "Off-label use of recombinant factor VIIa in patients following bone marrowtransplantation", BONE MAR TR, 28(4), 2001, pp. 405-407
17. Levesque, H; Borg, JY; Bossi, P; Goudemand, J; Guillet, B; Cabane, J
    Acquired haemophilia: diagnosis and therapeutic management.
    REVUE DE MEDECINE INTERNE
    
    H. Levesque et al., "Acquired haemophilia: diagnosis and therapeutic management.", REV MED IN, 22(9), 2001, pp. 854-866
18. Gill, JMR; Frayn, KN; Wootton, SA; Miller, GJ; Hardman, AE
    Effects of prior moderate exercise on exogenous and endogenous lipid metabolism and plasma factor VII activity
    CLINICAL SCIENCE
    
    J.M.R. Gill et al., "Effects of prior moderate exercise on exogenous and endogenous lipid metabolism and plasma factor VII activity", CLIN SCI, 100(5), 2001, pp. 517-527
19. Hansen, JB; Grimsgaard, S; Huseby, NE; Sandset, PM; Bonaa, KH
    Serum lipids and regulation of tissue factor-induced coagulation in middle-aged men
    THROMBOSIS RESEARCH
    
    J.B. Hansen et al., "Serum lipids and regulation of tissue factor-induced coagulation in middle-aged men", THROMB RES, 102(1), 2001, pp. 3-13
20. Hendriks, HGD; Meijer, K; de Wolf, JTM; Klompmaker, IJ; Porte, RJ; de Kam, PJ; Hagenaars, AJM; Melsen, T; Slooff, MJH; van der Meer, J
    Reduced transfusion requirements by recombinant factor VIIa in orthotopic liver transplantation - A pilot study
    TRANSPLANTATION
    
    H.G.D. Hendriks et al., "Reduced transfusion requirements by recombinant factor VIIa in orthotopic liver transplantation - A pilot study", TRANSPLANT, 71(3), 2001, pp. 402-405
21. Hoffman, M; Monroe, DM
    The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis
    SEMINARS IN HEMATOLOGY
    
    M. Hoffman e D.M. Monroe, "The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis", SEM HEMATOL, 38(4), 2001, pp. 6-9
22. Galan, AM; Tonda, R; Altisent, C; Maragall, S; Ordinas, A; Escolar, G
    Recombinant factor VIIa (NovoSeven (R)) restores deficient coagulation: Experience from an ex vivo model
    SEMINARS IN HEMATOLOGY
    
    A.M. Galan et al., "Recombinant factor VIIa (NovoSeven (R)) restores deficient coagulation: Experience from an ex vivo model", SEM HEMATOL, 38(4), 2001, pp. 10-14
23. Shapiro, A
    Inhibitor treatment: State of the art
    SEMINARS IN HEMATOLOGY
    
    A. Shapiro, "Inhibitor treatment: State of the art", SEM HEMATOL, 38(4), 2001, pp. 26-34
24. Roberts, HR
    Recombinant factor VIIa (NovoSeven (R)) and the safety of treatment
    SEMINARS IN HEMATOLOGY
    
    H.R. Roberts, "Recombinant factor VIIa (NovoSeven (R)) and the safety of treatment", SEM HEMATOL, 38(4), 2001, pp. 48-50
25. Friederich, PW; Levi, M; Bauer, KA; Vlasuk, GP; Rote, WE; Breederveld, D; Keller, T; Spataro, M; Barzegar, S; Buller, HR
    Ability of recombinant factor VIIa to generate thrombin during inhibition of tissue factor in human subjects
    CIRCULATION
    
    P.W. Friederich et al., "Ability of recombinant factor VIIa to generate thrombin during inhibition of tissue factor in human subjects", CIRCULATION, 103(21), 2001, pp. 2555-2559
26. Hunter, KA; Crosbie, LC; Horgan, GW; Miller, GJ; Dutta-Roy, AK
    Effect of diets rich in oleic acid, stearic acid and linoleic acid on postprandial haemostatic factors in young healthy men
    BRITISH JOURNAL OF NUTRITION
    
    K.A. Hunter et al., "Effect of diets rich in oleic acid, stearic acid and linoleic acid on postprandial haemostatic factors in young healthy men", BR J NUTR, 86(2), 2001, pp. 207-215
27. Moscardo, F; Perez, F; de la Rubia, J; Balerdi, B; Lorenzo, JI; Senent, ML; Aznar, I; Carceller, S; Sanz, MA
    Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII
    BRITISH JOURNAL OF HAEMATOLOGY
    
    F. Moscardo et al., "Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII", BR J HAEM, 114(1), 2001, pp. 174-176
28. Chaney, JD; Nielsen, VG
    Considerations for the hemophiliac patient with inhibitors to factor VIII
    ANESTHESIA AND ANALGESIA
    
    J.D. Chaney e V.G. Nielsen, "Considerations for the hemophiliac patient with inhibitors to factor VIII", ANESTH ANAL, 92(3), 2001, pp. 785-786
29. Chaney, JD; Nielsen, VG
    Considerations for the hemophiliac patient with inhibitors to factor VIII
    ANESTHESIA AND ANALGESIA
    
    J.D. Chaney e V.G. Nielsen, "Considerations for the hemophiliac patient with inhibitors to factor VIII", ANESTH ANAL, 92(3), 2001, pp. 785-786
30. Sanders, TAB; Oakley, FR; Cooper, JA; Miller, GJ
    Influence of a stearic acid-rich structured triacylglycerol on postprandial lipemia, factor VII concentrations, and fibrinolytic activity in healthy subjects
    AMERICAN JOURNAL OF CLINICAL NUTRITION
    
    T.A.B. Sanders et al., "Influence of a stearic acid-rich structured triacylglycerol on postprandial lipemia, factor VII concentrations, and fibrinolytic activity in healthy subjects", AM J CLIN N, 73(4), 2001, pp. 715-721
31. Gale, AJ; Gordon, SG
    Update on tumor cell procoagulant factors
    ACTA HAEMATOLOGICA
    
    A.J. Gale e S.G. Gordon, "Update on tumor cell procoagulant factors", ACT HAEMAT, 106(1-2), 2001, pp. 25-32
32. Martinowitz, U; Holcomb, JB; Pusateri, AE; Stein, M; Onaca, N; Freidman, M; Macaitis, JM; Castel, D; Hedner, U; Hess, JR
    Intravenous rFVIIa administered for hemorrhage control in hypothermic coagulopathic swine with grade V liver injuries
    JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE
    
    U. Martinowitz et al., "Intravenous rFVIIa administered for hemorrhage control in hypothermic coagulopathic swine with grade V liver injuries", J TRAUMA, 50(4), 2001, pp. 721-729
33. Lusher, JM
    Inhibitors in young boys with haemophilia
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    
    J.M. Lusher, "Inhibitors in young boys with haemophilia", BEST P R C, 13(3), 2000, pp. 457-468
34. Jimenez-Yuste, V; Villar, A; Morado, M; Canales, M; Hernandez, MC; Sanjurjo, MJ; Quintana, M; Hernandez-Navarro, F
    Continuous infusion of recombinant activated factor VII during caesarean section delivery in a patient with congenital factor VII deficiency
    HAEMOPHILIA
    
    V. Jimenez-Yuste et al., "Continuous infusion of recombinant activated factor VII during caesarean section delivery in a patient with congenital factor VII deficiency", HAEMOPHILIA, 6(5), 2000, pp. 588-590
35. Ton-That, TT; Doron, D; Pollard, BS; Bacher, J; Pollard, HB
    In vivo bypass of hemophilia A coagulation defect by Factor XIIa implant
    NATURE BIOTECHNOLOGY
    
    T.T. Ton-That et al., "In vivo bypass of hemophilia A coagulation defect by Factor XIIa implant", NAT BIOTECH, 18(3), 2000, pp. 289-295
36. Ollivier, V; Chabbat, J; Herbert, JM; Hakim, J; de Prost, D
    Vascular endothelial growth factor production by fibroblasts in response to factor VIIa binding to tissue factor involves thrombin and factor Xa
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    
    V. Ollivier et al., "Vascular endothelial growth factor production by fibroblasts in response to factor VIIa binding to tissue factor involves thrombin and factor Xa", ART THROM V, 20(5), 2000, pp. 1374-1381
37. Bladbjerg, EM; Larsen, LF; Ostergaard, P; Jespersen, J
    In vitro effects of heparin and tissue factor pathway inhibitor on factor VII assays. Possible implications for measurements in vivo after heparin therapy
    BLOOD COAGULATION & FIBRINOLYSIS
    
    E.M. Bladbjerg et al., "In vitro effects of heparin and tissue factor pathway inhibitor on factor VII assays. Possible implications for measurements in vivo after heparin therapy", BL COAG FIB, 11(8), 2000, pp. 739-745
38. Streif, W; Paes, B; Berry, L; Andrew, M; Andreasen, RB; Chan, AKC
    Influence of exogenous factor VIIa on thrombin generation in cord plasma of full-term and pre-term newborns
    BLOOD COAGULATION & FIBRINOLYSIS
    
    W. Streif et al., "Influence of exogenous factor VIIa on thrombin generation in cord plasma of full-term and pre-term newborns", BL COAG FIB, 11(4), 2000, pp. 349-357
39. Arkin, S; Blei, F; Fetten, J; Foulke, R; Gilchrist, GS; Heisel, MA; Key, N; Kisker, CT; Kitchen, C; Shafer, FE; Shah, PC; Strickland, D
    Human coagulation factor FVIIa (recombinant) in the management of limb-threatening bleeds unresponsive to alternative therapies: results from the NovoSeven (R) emergency-use programme in patients with severe haemophilia or with acquired inhibitors
    BLOOD COAGULATION & FIBRINOLYSIS
    
    S. Arkin et al., "Human coagulation factor FVIIa (recombinant) in the management of limb-threatening bleeds unresponsive to alternative therapies: results from the NovoSeven (R) emergency-use programme in patients with severe haemophilia or with acquired inhibitors", BL COAG FIB, 11(3), 2000, pp. 255-259
40. Negrier, C; Lienhart, A
    Overall experience with NovoSeven (R)
    BLOOD COAGULATION & FIBRINOLYSIS
    
    C. Negrier e A. Lienhart, "Overall experience with NovoSeven (R)", BL COAG FIB, 11, 2000, pp. S19-S24
41. Kenet, G; Lubetsky, A; Gitel, S; Luboshitz, J; Varon, D; Martinowitz, U
    Treatment of bleeding episodes in patients with hemophilia and an inhibitor: comparison of two treatment protocols with recombinant activated factor VII
    BLOOD COAGULATION & FIBRINOLYSIS
    
    G. Kenet et al., "Treatment of bleeding episodes in patients with hemophilia and an inhibitor: comparison of two treatment protocols with recombinant activated factor VII", BL COAG FIB, 11, 2000, pp. S35-S38
42. Brackmann, HH; Effenberger, E; Hess, L; Schwaab, R; Oldenburg, J
    NovoSeven (R) in immune tolerance therapy
    BLOOD COAGULATION & FIBRINOLYSIS
    
    H.H. Brackmann et al., "NovoSeven (R) in immune tolerance therapy", BL COAG FIB, 11, 2000, pp. S39-S44
43. Hedner, U
    NovoSeven (R) as a universal haemostatic agent
    BLOOD COAGULATION & FIBRINOLYSIS
    
    U. Hedner, "NovoSeven (R) as a universal haemostatic agent", BL COAG FIB, 11, 2000, pp. S107-S111
44. Berntorp, E; Stigendal, L; Lethagen, S; Olofsson, L; Hedner, U
    NovoSeven (R) in warfarin-treated patients
    BLOOD COAGULATION & FIBRINOLYSIS
    
    E. Berntorp et al., "NovoSeven (R) in warfarin-treated patients", BL COAG FIB, 11, 2000, pp. S113-S115
45. Al Douri, M; Shafi, T; Al Khudairi, D; Al Bokhari, E; Black, L; Akinwale, N; Musa, MO; Al Homaidhi, A; Al Fagih, M; Andreasen, RB
    Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven (R)) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery
    BLOOD COAGULATION & FIBRINOLYSIS
    
    M. Al Douri et al., "Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven (R)) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery", BL COAG FIB, 11, 2000, pp. S121-S127
46. Arnljots, B; Soderstrom, T; Ezban, M; Hedner, U
    Effect of locally-applied active site-blocked activated factor VII (ASIS) on experimental arterial thrombosis
    BLOOD COAGULATION & FIBRINOLYSIS
    
    B. Arnljots et al., "Effect of locally-applied active site-blocked activated factor VII (ASIS) on experimental arterial thrombosis", BL COAG FIB, 11, 2000, pp. S145-S148
47. Golino, P; Ragni, M; Cirillo, P; D'Andrea, D; Ravera, M; Calabro, P; Ezban, M; Tommasini, P; Chiariello, M
    Effects of recombinant active site-blocked activated factor VII in rabbit models of carotid stenosis and myocardial infarction
    BLOOD COAGULATION & FIBRINOLYSIS
    
    P. Golino et al., "Effects of recombinant active site-blocked activated factor VII in rabbit models of carotid stenosis and myocardial infarction", BL COAG FIB, 11, 2000, pp. S149-S158
48. de Maat, MPM; Pijl, H; Kluft, C; Princen, HMG
    Consumption of black and green tea has no effect on inflammation, haemostasis and endothelial markers in smoking healthy individuals
    EUROPEAN JOURNAL OF CLINICAL NUTRITION
    
    M.P.M. de Maat et al., "Consumption of black and green tea has no effect on inflammation, haemostasis and endothelial markers in smoking healthy individuals", EUR J CL N, 54(10), 2000, pp. 757-763
49. Mrozikiewicz, PM; Cascorbi, I; Ziemer, S; Laule, M; Meisel, C; Stangl, V; Rutsch, W; Wernecke, K; Baumann, G; Roots, I; Stangl, K
    Reduced procedural risk for coronary catheter interventions in carriers ofthe coagulation factor VII-Gln(353) gene
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    
    P.M. Mrozikiewicz et al., "Reduced procedural risk for coronary catheter interventions in carriers ofthe coagulation factor VII-Gln(353) gene", J AM COL C, 36(5), 2000, pp. 1520-1525
50. Golino, P; Ragni, M; Cirillo, P; Scognamiglio, A; Ravera, A; Buono, C; Guarino, A; Piro, O; Lambiase, C; Botticella, F; Ezban, M; Condorelli, M; Chiariello, M
    Recombinant human, active site-blocked factor VIIa reduces infarct size and no-reflow phenomenon in rabbits
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
    
    P. Golino et al., "Recombinant human, active site-blocked factor VIIa reduces infarct size and no-reflow phenomenon in rabbits", AM J P-HEAR, 278(5), 2000, pp. H1507-H1516
51. Aledort, LM
    Recombinant factor VIIa is a pan-hemostatic agent?
    THROMBOSIS AND HAEMOSTASIS
    
    L.M. Aledort, "Recombinant factor VIIa is a pan-hemostatic agent?", THROMB HAEM, 83(5), 2000, pp. 637-638
52. Miller, GJ; Howarth, DJ; Attfield, JC; Cooke, CJ; Nanjee, MN; Olszewski, WL; Morrissey, JH; Miller, NE
    Haemostatic factors in human peripheral afferent lymph
    THROMBOSIS AND HAEMOSTASIS
    
    G.J. Miller et al., "Haemostatic factors in human peripheral afferent lymph", THROMB HAEM, 83(3), 2000, pp. 427-432
53. Monroe, DM; Hoffman, M; Allen, GA; Roberts, HR
    The factor VII-Platelet interplay: Effectiveness of recombinant factor VIIa in the treatment of bleeding in severe thrombocytopathia
    SEMINARS IN THROMBOSIS AND HEMOSTASIS
    
    D.M. Monroe et al., "The factor VII-Platelet interplay: Effectiveness of recombinant factor VIIa in the treatment of bleeding in severe thrombocytopathia", SEM THROMB, 26(4), 2000, pp. 373-377
54. Erhardtsen, E
    Pharmacokinetics of recombinant activated factor VII (rFVIIa)
    SEMINARS IN THROMBOSIS AND HEMOSTASIS
    
    E. Erhardtsen, "Pharmacokinetics of recombinant activated factor VII (rFVIIa)", SEM THROMB, 26(4), 2000, pp. 385-391
55. Hunault, M; Bauer, KA
    Recombinant factor VIIa for the treatment of congenital factor VII deficiency
    SEMINARS IN THROMBOSIS AND HEMOSTASIS
    
    M. Hunault e K.A. Bauer, "Recombinant factor VIIa for the treatment of congenital factor VII deficiency", SEM THROMB, 26(4), 2000, pp. 401-405
56. Negrier, C; Hay, CRM
    The treatment of bleeding in hemophilic patients with inhibitors with recombinant factor VIIa
    SEMINARS IN THROMBOSIS AND HEMOSTASIS
    
    C. Negrier e C.R.M. Hay, "The treatment of bleeding in hemophilic patients with inhibitors with recombinant factor VIIa", SEM THROMB, 26(4), 2000, pp. 407-412
57. Hansen, JB; Svensson, B; Sandset, PM; Thijssen, F
    Reduction of factor FVIIa activity during heparin therapy evidence for assay interactions with tissue factor pathway inhibitor and antithrombin
    THROMBOSIS RESEARCH
    
    J.B. Hansen et al., "Reduction of factor FVIIa activity during heparin therapy evidence for assay interactions with tissue factor pathway inhibitor and antithrombin", THROMB RES, 100(5), 2000, pp. 389-396
58. Josic, D; Hoffer, L; Buchacher, A; Schwinn, H; Frenzel, W; Biesert, L; Klocking, HP; Hellstern, R; Rokicka-Milewska, R; Klukowska, A
    Manufacturing of a prothrombin complex concentrate aiming at low thrombogenicity
    THROMBOSIS RESEARCH
    
    D. Josic et al., "Manufacturing of a prothrombin complex concentrate aiming at low thrombogenicity", THROMB RES, 100(5), 2000, pp. 433-441
59. Saigo, M; Abe, S; Ogawa, M; Biro, S; Minagoe, S; Maruyama, I; Toda, H; Kiyonaga, K; Atsuchi, Y; Tahara, M; Mawatari, K; Tei, C
    Plasma level of triglyceride-rich lipoprotein remnants is closely associated with the activation of coagulation factor VII in patients with myocardial infarction
    THROMBOSIS RESEARCH
    
    M. Saigo et al., "Plasma level of triglyceride-rich lipoprotein remnants is closely associated with the activation of coagulation factor VII in patients with myocardial infarction", THROMB RES, 100(1), 2000, pp. 9-17
60. Sanders, TAB; de Grassi, T; Miller, GJ; Morrissey, JH
    Influence of fatty acid chain length and cis/trans isomerization on postprandial lipemia and factor VII in healthy subjects (postprandial lipids and factor VII)
    ATHEROSCLEROSIS
    
    T.A.B. Sanders et al., "Influence of fatty acid chain length and cis/trans isomerization on postprandial lipemia and factor VII in healthy subjects (postprandial lipids and factor VII)", ATHEROSCLER, 149(2), 2000, pp. 413-420
61. Cooper, JA; Miller, GJ; Bauer, KA; Morrissey, JH; Meade, TW; Howarth, DJ; Barzegar, S; Mitchell, JP; Rosenberg, RD
    Comparison of novel hemostatic factors and conventional risk factors for prediction of coronary heart disease
    CIRCULATION
    
    J.A. Cooper et al., "Comparison of novel hemostatic factors and conventional risk factors for prediction of coronary heart disease", CIRCULATION, 102(23), 2000, pp. 2816-2822
62. Green, D
    Complications associated with the treatment of haemophiliacs with inhibitors
    HAEMOPHILIA
    
    D. Green, "Complications associated with the treatment of haemophiliacs with inhibitors", HAEMOPHILIA, 5, 1999, pp. 11-17
63. Teitel, JM
    Recombinant factor VIIa versus aPCCs in haemophiliacs with inhibitors: treatment and cost considerations
    HAEMOPHILIA
    
    J.M. Teitel, "Recombinant factor VIIa versus aPCCs in haemophiliacs with inhibitors: treatment and cost considerations", HAEMOPHILIA, 5, 1999, pp. 43-49
64. Mariani, G; Conard, J; Bernardi, F; Bertina, R; Garcia, VV; Prydz, H; Samama, M; Sandset, PM; Puopolo, N; Ciarla, MV; Poso, R; Di Nucci, GD; Ceci, F; Marchetti, G
    Oral contraceptives highlight the genotype-specific association between serum phospholipids and activated factor VII
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    
    G. Mariani et al., "Oral contraceptives highlight the genotype-specific association between serum phospholipids and activated factor VII", ART THROM V, 19(8), 1999, pp. 2024-2028
65. Tamaki, S; Iwai, N; Nakamura, Y; Tsujita, Y; Kinoshita, M
    Variation of the factor VII gene and ischemic heart disease in Japanese subjects
    CORONARY ARTERY DISEASE
    
    S. Tamaki et al., "Variation of the factor VII gene and ischemic heart disease in Japanese subjects", CORON ART D, 10(8), 1999, pp. 601-606
66. Tsujioka, H; Suehiro, A; Kakishita, E
    Activation of coagulation factor VII by tissue-type plasminogen activator
    AMERICAN JOURNAL OF HEMATOLOGY
    
    H. Tsujioka et al., "Activation of coagulation factor VII by tissue-type plasminogen activator", AM J HEMAT, 61(1), 1999, pp. 34-39
67. Harris, GM; Stendt, CL; Vollenhoven, BJ; Gan, TE; Tipping, PG
    Decreased plasma tissue factor pathway inhibitor in women taking combined oral contraceptives
    AMERICAN JOURNAL OF HEMATOLOGY
    
    G.M. Harris et al., "Decreased plasma tissue factor pathway inhibitor in women taking combined oral contraceptives", AM J HEMAT, 60(3), 1999, pp. 175-180
68. Staudinger, T; Frass, M; Rintelen, C; Quehenberger, P; Wagner, O; Stoiser, B; Locker, GJ; Laczika, K; Knapp, S; Watzke, H
    Influence of prothrombin complex concentrates on plasma coagulation in critically ill patients
    INTENSIVE CARE MEDICINE
    
    T. Staudinger et al., "Influence of prothrombin complex concentrates on plasma coagulation in critically ill patients", INTEN CAR M, 25(10), 1999, pp. 1105-1110
69. Scarabin, PY; Vissac, AM; Kirzin, JM; Bourgeat, P; Amiral, J; Agher, R; Guize, L
    Elevated plasma fibrinogen and increased fibrin turnover among healthy women who both smoke and use low-dose oral contraceptives - A preliminary report
    THROMBOSIS AND HAEMOSTASIS
    
    P.Y. Scarabin et al., "Elevated plasma fibrinogen and increased fibrin turnover among healthy women who both smoke and use low-dose oral contraceptives - A preliminary report", THROMB HAEM, 82(3), 1999, pp. 1112-1116
70. Ruf, W; Mueller, BM
    Tissue factor signaling
    THROMBOSIS AND HAEMOSTASIS
    
    W. Ruf e B.M. Mueller, "Tissue factor signaling", THROMB HAEM, 82(2), 1999, pp. 175-182
71. Hedner, U
    Treatment of patients with factor VIII and factor IX inhibitors with special focus on the use of recombinant factor VIIa
    THROMBOSIS AND HAEMOSTASIS
    
    U. Hedner, "Treatment of patients with factor VIII and factor IX inhibitors with special focus on the use of recombinant factor VIIa", THROMB HAEM, 82(2), 1999, pp. 531-539
72. Hellstern, P
    Production and composition of prothrombin complex concentrates: Correlation between composition and therapeutic efficiency
    THROMBOSIS RESEARCH
    
    P. Hellstern, "Production and composition of prothrombin complex concentrates: Correlation between composition and therapeutic efficiency", THROMB RES, 95(4), 1999, pp. S7-S12
73. Sanders, TAB; de Grassi, T; Miller, GJ; Humphries, SE
    Dietary oleic and palmitic acids and postprandial factor VII in middle-aged men heterozygous and homozygous for factor VII R353Q polymorphism
    AMERICAN JOURNAL OF CLINICAL NUTRITION
    
    T.A.B. Sanders et al., "Dietary oleic and palmitic acids and postprandial factor VII in middle-aged men heterozygous and homozygous for factor VII R353Q polymorphism", AM J CLIN N, 69(2), 1999, pp. 220-225
74. DANIELSEN R; ONUNDARSON PT; THORS H; VIDARSSON B; MORRISSEY JH
    ACTIVATED AND TOTAL COAGULATION-FACTOR-VII, AND FIBRINOGEN IN CORONARY-ARTERY DISEASE
    SCANDINAVIAN CARDIOVASCULAR JOURNAL
    
    R. Danielsen et al., "ACTIVATED AND TOTAL COAGULATION-FACTOR-VII, AND FIBRINOGEN IN CORONARY-ARTERY DISEASE", SC CARDIOVA, 32(2), 1998, pp. 87-95
75. SCHULMAN S
    SAFETY, EFFICACY AND LESSONS FROM CONTINUOUS-INFUSION WITH RFVIIA
    Haemophilia
    
    S. Schulman, "SAFETY, EFFICACY AND LESSONS FROM CONTINUOUS-INFUSION WITH RFVIIA", Haemophilia, 4(4), 1998, pp. 564-567
76. Lusher, JM; Roberts, HR; Davignon, G; Joist, JH; Smith, H; Shapiro, A; Laurian, Y; Kasper, CK; Mannucci, PM
    A randomized, double-blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors
    HAEMOPHILIA
    
    J.M. Lusher et al., "A randomized, double-blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors", HAEMOPHILIA, 4(6), 1998, pp. 790-798
77. GOUDEMAND J
    RECOMBINANT FACTOR VIIA - A NEW TREATMENT OF HEMOPHILIA
    Transfusion clinique et biologique
    
    J. Goudemand, "RECOMBINANT FACTOR VIIA - A NEW TREATMENT OF HEMOPHILIA", Transfusion clinique et biologique, 5(4), 1998, pp. 260-265
78. CARDIGAN RA; DONOHOE S; PURDY G; MACKIE IJ; MACHIN SJ
    THE ASSOCIATION OF FACTOR VIIA, FACTOR XIIA AND BETA(2)-GLYCOPROTEIN-1 WITH TRIGLYCERIDE-RICH LIPOPROTEINS IN NORMOLIPIDEMIC SUBJECTS
    Blood coagulation & fibrinolysis
    
    R.A. Cardigan et al., "THE ASSOCIATION OF FACTOR VIIA, FACTOR XIIA AND BETA(2)-GLYCOPROTEIN-1 WITH TRIGLYCERIDE-RICH LIPOPROTEINS IN NORMOLIPIDEMIC SUBJECTS", Blood coagulation & fibrinolysis, 9(4), 1998, pp. 323-332
79. MENART C; COGNET V; PETIT PY; MASSIGNON D; NEGRIER C
    MANAGEMENT OF AN ANTI-FACTOR-VIII INHIBITOR OCCURRING DURING SURGICAL-PROCEDURE WITH CONTINUOUS-INFUSION OF NOVOSEVEN(R)
    Blood coagulation & fibrinolysis
    
    C. Menart et al., "MANAGEMENT OF AN ANTI-FACTOR-VIII INHIBITOR OCCURRING DURING SURGICAL-PROCEDURE WITH CONTINUOUS-INFUSION OF NOVOSEVEN(R)", Blood coagulation & fibrinolysis, 9(3), 1998, pp. 289-290
80. LUSHER J; INGERSLEV J; ROBERTS H; HEDNER U
    CLINICAL-EXPERIENCE WITH RECOMBINANT FACTOR VIIA
    Blood coagulation & fibrinolysis
    
    J. Lusher et al., "CLINICAL-EXPERIENCE WITH RECOMBINANT FACTOR VIIA", Blood coagulation & fibrinolysis, 9(2), 1998, pp. 119-128
81. HEDNER U; INGERSLEV J
    CLINICAL USE OF RECOMBINANT FVIIA (RFVIIA)
    Transfusion science
    
    U. Hedner e J. Ingerslev, "CLINICAL USE OF RECOMBINANT FVIIA (RFVIIA)", Transfusion science, 19(2), 1998, pp. 163-176
82. MARCKMANN P; BLADBJERG EM; JESPERSEN J
    DIET AND BLOOD-COAGULATION FACTOR-VII - A KEY PROTEIN IN ARTERIAL THROMBOSIS
    European journal of clinical nutrition
    
    P. Marckmann et al., "DIET AND BLOOD-COAGULATION FACTOR-VII - A KEY PROTEIN IN ARTERIAL THROMBOSIS", European journal of clinical nutrition, 52(2), 1998, pp. 75-84
83. PAPADAKI HA; XYLOURI I; VALATAS W; PETINARAKIS J; KONTOPOULOU I; ELIOPOULOS GD
    SEVERE ACQUIRED HEMOPHILIA-A SUCCESSFULLY TREATED WITH ACTIVATED RECOMBINANT HUMAN FACTOR-VII
    Annals of hematology
    
    H.A. Papadaki et al., "SEVERE ACQUIRED HEMOPHILIA-A SUCCESSFULLY TREATED WITH ACTIVATED RECOMBINANT HUMAN FACTOR-VII", Annals of hematology, 77(3), 1998, pp. 123-125
84. IRISH AB; GREEN FR
    FACTOR-VII COAGULANT ACTIVITY (VIIC) AND HYPERCOAGULABILITY IN CHRONIC RENAL-DISEASE AND DIALYSIS - RELATIONSHIP WITH DYSLIPIDEMIA, INFLAMMATION, AND FACTOR-VII GENOTYPE
    Nephrology, dialysis, transplantation
    
    A.B. Irish e F.R. Green, "FACTOR-VII COAGULANT ACTIVITY (VIIC) AND HYPERCOAGULABILITY IN CHRONIC RENAL-DISEASE AND DIALYSIS - RELATIONSHIP WITH DYSLIPIDEMIA, INFLAMMATION, AND FACTOR-VII GENOTYPE", Nephrology, dialysis, transplantation, 13(3), 1998, pp. 679-684
85. SHAPIRO AD; GILCHRIST GS; HOOTS WK; COOPER HA; GASTINEAU DA
    PROSPECTIVE, RANDOMIZED TRIAL OF 2 DOSES OF RFVIIA (NOVOSEVEN) IN HEMOPHILIA PATIENTS WITH INHIBITORS UNDERGOING SURGERY
    Thrombosis and haemostasis
    
    A.D. Shapiro et al., "PROSPECTIVE, RANDOMIZED TRIAL OF 2 DOSES OF RFVIIA (NOVOSEVEN) IN HEMOPHILIA PATIENTS WITH INHIBITORS UNDERGOING SURGERY", Thrombosis and haemostasis, 80(5), 1998, pp. 773-778
86. KOHLER M; HELLSTERN P; LECHLER E; UBERFUHR P; MULLERBERGHAUS G
    THROMBOEMBOLIC COMPLICATIONS ASSOCIATED WITH THE USE OF PROTHROMBIN COMPLEX AND FACTOR-IX CONCENTRATES
    Thrombosis and haemostasis
    
    M. Kohler et al., "THROMBOEMBOLIC COMPLICATIONS ASSOCIATED WITH THE USE OF PROTHROMBIN COMPLEX AND FACTOR-IX CONCENTRATES", Thrombosis and haemostasis, 80(3), 1998, pp. 399-402
87. PANKOW JS; FOLSOM AR; SHAHAR E; TSAI MY; JEFFERY RW; WING RR
    WEIGHT-LOSS INDUCED CHANGES IN PLASMA FACTOR-VII COAGULANT ACTIVITY AND RELATION TO THE FACTOR-VII ARG GLN(353) POLYMORPHISM IN MODERATELY OBESE ADULTS/
    Thrombosis and haemostasis
    
    J.S. Pankow et al., "WEIGHT-LOSS INDUCED CHANGES IN PLASMA FACTOR-VII COAGULANT ACTIVITY AND RELATION TO THE FACTOR-VII ARG GLN(353) POLYMORPHISM IN MODERATELY OBESE ADULTS/", Thrombosis and haemostasis, 79(4), 1998, pp. 784-789
88. WRIGHT D; POLLER L; THOMSON JM; SIDEBOTHAM A; HIRST CF; HIRSCH P
    A LONGITUDINAL-STUDY OF THE FACTOR-VII RISE DURING PREGNANCY
    Thrombosis and haemostasis
    
    D. Wright et al., "A LONGITUDINAL-STUDY OF THE FACTOR-VII RISE DURING PREGNANCY", Thrombosis and haemostasis, 79(2), 1998, pp. 328-330
89. Key, NS; Aledort, LM; Beardsley, D; Cooper, HA; Davignon, G; Ewenstein, BM; Gilchrist, GS; Gill, JC; Glader, B; Hoots, WK; Kisker, CT; Lusher, JM; Rosenfield, CG; Shapiro, AD; Smith, H; Taft, E
    Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors
    THROMBOSIS AND HAEMOSTASIS
    
    N.S. Key et al., "Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors", THROMB HAEM, 80(6), 1998, pp. 912-918
90. GOLINO P; RAGNI M; CIRILLO P; DANDREA D; SCOGNAMIGLIO A; RAVERA A; BUONO C; EZBAN M; CORCIONE N; VIGORITO F; CONDORELLI M; CHIARIELLO M
    ANTITHROMBOTIC EFFECTS OF RECOMBINANT HUMAN, ACTIVE SITE-BLOCKED FACTOR VIIA IN A RABBIT MODEL OF RECURRENT ARTERIAL THROMBOSIS
    Circulation research
    
    P. Golino et al., "ANTITHROMBOTIC EFFECTS OF RECOMBINANT HUMAN, ACTIVE SITE-BLOCKED FACTOR VIIA IN A RABBIT MODEL OF RECURRENT ARTERIAL THROMBOSIS", Circulation research, 82(1), 1998, pp. 39-46
91. Ghaddar, HM; Folsom, AR; Aleksic, N; Hearne, LB; Chambless, LE; Morrissey, JH; Wu, KK
    Correlation of factor VIIa values with factor VII gene polymorphism, fasting and postprandial triglyceride levels, and subclinical carotid atherosclerosis
    CIRCULATION
    
    H.M. Ghaddar et al., "Correlation of factor VIIa values with factor VII gene polymorphism, fasting and postprandial triglyceride levels, and subclinical carotid atherosclerosis", CIRCULATION, 98(25), 1998, pp. 2815-2821
92. DEMOERLOOSE P; AMIRAL J; VISSAC AM; REBER G
    LONGITUDINAL-STUDY ON ACTIVATED FACTOR-XII AND FACTOR-VII LEVELS DURING NORMAL-PREGNANCY
    British Journal of Haematology
    
    P. Demoerloose et al., "LONGITUDINAL-STUDY ON ACTIVATED FACTOR-XII AND FACTOR-VII LEVELS DURING NORMAL-PREGNANCY", British Journal of Haematology, 100(1), 1998, pp. 40-44
93. GREEN D; CHAMBERLAIN MA; RUTH KJ; FOLSOM AR; LIU K
    FACTOR-VII, CHOLESTEROL, AND TRIGLYCERIDES - THE CARDIA STUDY
    Arteriosclerosis, thrombosis, and vascular biology
    
    D. Green et al., "FACTOR-VII, CHOLESTEROL, AND TRIGLYCERIDES - THE CARDIA STUDY", Arteriosclerosis, thrombosis, and vascular biology, 17(1), 1997, pp. 51-55
94. COBOS E; KEUNG YKK; AKHTER S; JONES J
    USE OF RECOMBINANT FACTOR VIIA FOR MAJOR ELECTIVE SURGERY IN A PATIENT WITH FACTOR-VII DEFICIENCY, RETROPERITONEAL FIBROSIS AND HYDRONEPHROSIS
    Clinical and applied thrombosis/hemostasis
    
    E. Cobos et al., "USE OF RECOMBINANT FACTOR VIIA FOR MAJOR ELECTIVE SURGERY IN A PATIENT WITH FACTOR-VII DEFICIENCY, RETROPERITONEAL FIBROSIS AND HYDRONEPHROSIS", Clinical and applied thrombosis/hemostasis, 3(1), 1997, pp. 33-35
95. NISHIUMA S; KARIO K; NAKANISHI K; YAKUSHIJIN K; KAGEYAMA G; MATSUNAKA T; MATSUO T; KANAI N; IKEDA U; SHIMADA K; MATSUO M
    FACTOR-VII R353Q POLYMORPHISM AND LACUNAR STROKE IN JAPANESE HYPERTENSIVE PATIENTS AND NORMOTENSIVE CONTROLS
    Blood coagulation & fibrinolysis
    
    S. Nishiuma et al., "FACTOR-VII R353Q POLYMORPHISM AND LACUNAR STROKE IN JAPANESE HYPERTENSIVE PATIENTS AND NORMOTENSIVE CONTROLS", Blood coagulation & fibrinolysis, 8(8), 1997, pp. 525-530
96. MILLER GJ
    DIETARY FATTY-ACIDS AND BLOOD-COAGULATION
    Prostaglandins, leukotrienes and essential fatty acids
    
    G.J. Miller, "DIETARY FATTY-ACIDS AND BLOOD-COAGULATION", Prostaglandins, leukotrienes and essential fatty acids, 57(4-5), 1997, pp. 389-394
97. NAKASE T; WADA H; WAKITA Y; KANEKO T; DEGUCHI H; HIYOYAMA K; SHIMURA M; MORI Y; SHIKU H
    PLASMA-ACTIVATED FACTOR-VII LEVEL IN PATIENTS POSITIVE FOR LUPUS ANTICOAGULANT
    American journal of hematology
    
    T. Nakase et al., "PLASMA-ACTIVATED FACTOR-VII LEVEL IN PATIENTS POSITIVE FOR LUPUS ANTICOAGULANT", American journal of hematology, 55(1), 1997, pp. 9-14
98. MORRISSEY JH; NEUENSCHWANDER PF; HUANG QL; MCCALLUM CD; SU BX; JOHNSON AE
    FACTOR VIIA TISSUE FACTOR - FUNCTIONAL IMPORTANCE OF PROTEIN-MEMBRANEINTERACTIONS
    Thrombosis and haemostasis
    
    J.H. Morrissey et al., "FACTOR VIIA TISSUE FACTOR - FUNCTIONAL IMPORTANCE OF PROTEIN-MEMBRANEINTERACTIONS", Thrombosis and haemostasis, 78(1), 1997, pp. 112-116
99. LUBON H; PALEYANDA RK
    VITAMIN-K-DEPENDENT PROTEIN-PRODUCTION IN TRANSGENIC ANIMALS
    Thrombosis and haemostasis
    
    H. Lubon e R.K. Paleyanda, "VITAMIN-K-DEPENDENT PROTEIN-PRODUCTION IN TRANSGENIC ANIMALS", Thrombosis and haemostasis, 78(1), 1997, pp. 532-536
100. MATSUO T; KOIDE M; KARIO K; SUZUKI S; MATSUO M
     EXTRINSIC COAGULATION-FACTORS AND TISSUE FACTOR PATHWAY INHIBITOR IN END-STAGE CHRONIC-RENAL-FAILURE
     Haemostasis
     
     T. Matsuo et al., "EXTRINSIC COAGULATION-FACTORS AND TISSUE FACTOR PATHWAY INHIBITOR IN END-STAGE CHRONIC-RENAL-FAILURE", Haemostasis, 27(4), 1997, pp. 163-167